Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MBTD1 | Q05BQ5 | 3/20 | 0.40 |
| ▸ | L3MBTL3 | Q96JM7 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22313951 | 0.86 | MBTD1 (0.38) | MBTD1L3MBTL3L3MBTL1 | |
| SCHEMBL23682872 | 0.86 | MBTD1 (0.40) | MBTD1L3MBTL3L3MBTL1 | |
| SCHEMBL4072871 | 0.83 | SLC6A2 (0.33) | MBTD1L3MBTL3 | |
| SCHEMBL16878115 | 0.82 | EPAS1 (0.32) | MBTD1L3MBTL3 | |
| SCHEMBL15706823 | 0.82 | EPAS1 (0.32) | MBTD1L3MBTL3 | |
| SCHEMBL1317662 | 0.82 | — | — | |
| SCHEMBL16878575 | 0.81 | MEN1 (0.32) | — | |
| Hydrochloric Acid SCHEMBL12539785 | 0.80 | MBTD1 (0.47) | MBTD1L3MBTL3L3MBTL1 | |
| SCHEMBL13382602 | 0.79 | — | — | |
| SCHEMBL22915706 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210228723-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. | 2021-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210228723-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | ZFX, F13B, GRN | MBTD1 2460/4885L3MBTL3 1368/4885L3MBTL1 718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.